October 2009 Volume 6 Number 10
Visit Nature Reviews Gastroenterology & Hepatology online to browse 
the journal.
Now available at 
http://links.ealert.nature.com/ctt?kn=74&m=34089817&r=MTc2OTYyOTQ2MwS2&b=2&j=NTg3MjEwNTES1&mt=1&rt=0
Please note that you need to be a subscriber to enjoy full text access 
to Nature Reviews Gastroenterology & Hepatology online. To purchase a 
subscription, please visit: 
http://links.ealert.nature.com/ctt?kn=30&m=34089817&r=MTc2OTYyOTQ2MwS2&b=2&j=NTg3MjEwNTES1&mt=1&rt=0
Alternatively, to recommend a subscription to your library, please visit
http://links.ealert.nature.com/ctt?kn=70&m=34089817&r=MTc2OTYyOTQ2MwS2&b=2&j=NTg3MjEwNTES1&mt=1&rt=0
*********************************************************************
Nature Reviews Gastroenterology & Hepatology Impact Factor: 4.550*
(*Journal Citation Reports, Thomson, 2005)
*********************************************************************
=========================== ADVERTISEMENT ===========================
That's my Purple Pill.
Click here to get the latest formulary status of NEXIUM(R) 
(esomeprazole magnesium) on plans in your area
http://links.ealert.nature.com/ctt?kn=33&m=34089817&r=MTc2OTYyOTQ2MwS2&b=2&j=NTg3MjEwNTES1&mt=1&rt=0
Source: AstraZeneca 286059 8/09
=====================================================================
=========================== ADVERTISEMENT ===========================
Nature Publishing Group is pleased to introduce gastrojobs...
Powered by naturejobs, the award-winning scientific and medical career 
placement service, gastrojobs is a unique, highly targeted site dedicated 
to recruiting the best researchers and medical professionals specializing 
in gastroenterology and hepatology.
Have your vacancies seen by the right candidates for FREE.
Visit gastrojobs to get started. 
http://links.ealert.nature.com/ctt?kn=63&m=34089817&r=MTc2OTYyOTQ2MwS2&b=2&j=NTg3MjEwNTES1&mt=1&rt=0
=====================================================================
----------------------
EDITORIAL
----------------------
The wrong end of the scope
Stephen B. Hanauer
p559 | doi:10.1038/nrgastro.2009.164
http://links.ealert.nature.com/ctt?kn=46&m=34089817&r=MTc2OTYyOTQ2MwS2&b=2&j=NTg3MjEwNTES1&mt=1&rt=0
----------------------
RESEARCH HIGHLIGHTS
----------------------
IBD: Risk of IBD increases after Salmonella or Campylobacter gastroenteritis
p561 | doi:10.1038/nrgastro.2009.152
http://links.ealert.nature.com/ctt?kn=56&m=34089817&r=MTc2OTYyOTQ2MwS2&b=2&j=NTg3MjEwNTES1&mt=1&rt=0
Esophagus: Longitudinal esophageal muscle dysfunction reported in 
eosinophilic esophagitis
p562 | doi:10.1038/nrgastro.2009.155
http://links.ealert.nature.com/ctt?kn=54&m=34089817&r=MTc2OTYyOTQ2MwS2&b=2&j=NTg3MjEwNTES1&mt=1&rt=0
Cancer: Asbestos exposure linked to digestive cancer
p562 | doi:10.1038/nrgastro.2009.156
http://links.ealert.nature.com/ctt?kn=52&m=34089817&r=MTc2OTYyOTQ2MwS2&b=2&j=NTg3MjEwNTES1&mt=1&rt=0
Cancer: Diabetes therapies affect pancreatic cancer risk
p563 | doi:10.1038/nrgastro.2009.151
http://links.ealert.nature.com/ctt?kn=50&m=34089817&r=MTc2OTYyOTQ2MwS2&b=2&j=NTg3MjEwNTES1&mt=1&rt=0
Chronic hepatitis C progression
p563 | doi:10.1038/nrgastro.2009.153
http://links.ealert.nature.com/ctt?kn=23&m=34089817&r=MTc2OTYyOTQ2MwS2&b=2&j=NTg3MjEwNTES1&mt=1&rt=0
Infectious disease: Typhoid vaccine effective
p563 | doi:10.1038/nrgastro.2009.154
http://links.ealert.nature.com/ctt?kn=16&m=34089817&r=MTc2OTYyOTQ2MwS2&b=2&j=NTg3MjEwNTES1&mt=1&rt=0
Surgery: Glycemic control after bariatric surgery
p564 | doi:10.1038/nrgastro.2009.157
http://links.ealert.nature.com/ctt?kn=18&m=34089817&r=MTc2OTYyOTQ2MwS2&b=2&j=NTg3MjEwNTES1&mt=1&rt=0
Endoscopy: Capsule endoscopy: a new technique for colon cancer screening?
p564 | doi:10.1038/nrgastro.2009.158
http://links.ealert.nature.com/ctt?kn=6&m=34089817&r=MTc2OTYyOTQ2MwS2&b=2&j=NTg3MjEwNTES1&mt=1&rt=0
----------------------
NEWS AND VIEWS
----------------------
Hepatitis: Monitoring drug therapy for hepatitis B-a global challenge?
Tin Nguyen and Stephen Locarnini
p565 | doi:10.1038/nrgastro.2009.160
A new study has found undetectable serum levels of HBV DNA at week 24 of 
treatment to be the strongest predictor of optimal outcomes for patients 
with chronic HBV infection. Although this finding is not surprising, it 
has important implications for those patients on antiviral therapy who 
do not achieve a favorable response.
http://links.ealert.nature.com/ctt?kn=7&m=34089817&r=MTc2OTYyOTQ2MwS2&b=2&j=NTg3MjEwNTES1&mt=1&rt=0
Colorectal cancer: What do studies of diet patterns tell us?
Marjorie L. McCullough
p567 | doi:10.1038/nrgastro.2009.159
Among the challenges of studying the contribution of individual dietary 
factors to cancer risk is the interwoven nature of diet-dietary factors 
are often correlated and eating patterns are complex. A large, prospective 
epidemiological study of diet patterns used cluster analyses to 
demonstrate the benefit of a fruit and vegetable diet to colorectal 
cancer risk.
http://links.ealert.nature.com/ctt?kn=44&m=34089817&r=MTc2OTYyOTQ2MwS2&b=2&j=NTg3MjEwNTES1&mt=1&rt=0
Colorectal cancer: Management of small polyps detected by CT colonography
Perry J. Pickhardt
p568 | doi:10.1038/nrgastro.2009.161
A recent survey of patients, primary physicians and gastroenterologists 
found that an overwhelming majority prefer endoscopic polypectomy for 
small polyps detected by screening CT colonography. These hypothetical 
results, however, strongly contradict results in actual clinical practice.
http://links.ealert.nature.com/ctt?kn=42&m=34089817&r=MTc2OTYyOTQ2MwS2&b=2&j=NTg3MjEwNTES1&mt=1&rt=0
Hepatitis C: CIFN for re-treatment of PEG-IFN plus RBV nonresponders?
Christian Trepo and Pierre Pradat
p570 | doi:10.1038/nrgastro.2009.145
The current re-treatment options available to patients with chronic 
hepatitis C who fail to respond to treatment with pegylated interferon 
plus ribavirin are limited. Findings from a large, multicenter study 
suggest that re-treatment with consensus interferon plus ribavirin 
should now be considered for compliant, motivated nonresponders.
http://links.ealert.nature.com/ctt?kn=38&m=34089817&r=MTc2OTYyOTQ2MwS2&b=2&j=NTg3MjEwNTES1&mt=1&rt=0
Surgery: A midline or transverse abdominal incision?
Henrik Kehlet
p571 | doi:10.1038/nrgastro.2009.150
Whether a midline or transverse incision is used in abdominal surgery 
depends mainly on the disease, anatomy and potential effects on wound 
healing, pain and postoperative complications. Decisions can, however, 
be based on a surgeon's experience and preference, as the procedures' 
respective benefits remain to be clearly delineated.
http://links.ealert.nature.com/ctt?kn=35&m=34089817&r=MTc2OTYyOTQ2MwS2&b=2&j=NTg3MjEwNTES1&mt=1&rt=0
----------------------
REVIEWS
----------------------
The clinical use of HVPG measurements in chronic liver disease
Jaime Bosch, Juan G. Abraldes, Annalisa Berzigotti and Juan Carlos 
Garcia-Pagan
Published online: 01 September 2009
p573 | doi:10.1038/nrgastro.2009.149
Hepatic venous pressure gradient (HVPG) is the most useful parameter 
for the assessment of patients with cirrhosis. HVPG provides diagnostic 
and prognostic information in several clinical scenarios: treatment of 
portal hypertension, surgery for hepatocellular carcinoma, treatment 
of HCV-related or HBV-related cirrhosis, and outcome of recurrent HCV 
infection after liver transplantation.
Abstract: http://links.ealert.nature.com/ctt?kn=45&m=34089817&r=MTc2OTYyOTQ2MwS2&b=2&j=NTg3MjEwNTES1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=71&m=34089817&r=MTc2OTYyOTQ2MwS2&b=2&j=NTg3MjEwNTES1&mt=1&rt=0
Pathophysiology, diagnosis and management of postoperative dumping 
syndrome
Jan Tack, Joris Arts, Philip Caenepeel, Dominiek De Wulf and Raf Bisschops
Published online: 01 September 2009
p583 | doi:10.1038/nrgastro.2009.148
The signs and symptoms of dumping syndrome, a well-established complication 
of gastric and esophageal surgery, result from rapid gastric emptying 
and the delivery of large particles of poorly digested food to the small 
bowel. These symptoms, which can be classed as early or late, their 
pathophysiological basis, and the treatment options available to patients 
with dumping syndrome are outlined in this article.
Abstract: http://links.ealert.nature.com/ctt?kn=80&m=34089817&r=MTc2OTYyOTQ2MwS2&b=2&j=NTg3MjEwNTES1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=61&m=34089817&r=MTc2OTYyOTQ2MwS2&b=2&j=NTg3MjEwNTES1&mt=1&rt=0
Advances in sexually transmitted infections of the gastrointestinal tract
Siew C. Ng and Brian Gazzard
Published online: 25 August 2009
p592 | doi:10.1038/nrgastro.2009.143
The gastrointestinal mucosa is an important target of many sexually 
transmitted infections-it is a site for HIV entry, replication and 
destruction of CD4+ T cells, and provides a niche for other sexually 
transmitted pathogens. This Review discusses the pathogenesis and 
gastrointestinal complications of HIV infection and summarizes advances 
in our understanding of other sexually transmitted infections of the 
gastrointestinal system.
Abstract: http://links.ealert.nature.com/ctt?kn=78&m=34089817&r=MTc2OTYyOTQ2MwS2&b=2&j=NTg3MjEwNTES1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=62&m=34089817&r=MTc2OTYyOTQ2MwS2&b=2&j=NTg3MjEwNTES1&mt=1&rt=0
Systemic amyloidosis and the gastrointestinal tract
Prayman T. Sattianayagam, Philip N. Hawkins and Julian D. Gillmore
Published online: 01 September 2009
p608 | doi:10.1038/nrgastro.2009.147
Systemic amyloidosis is characterized by the extracellular deposition 
of protein in an abnormal and insoluble form. Involvement of the 
gastrointestinal tract is very common but is often subclinical. This 
Review describes the gastrointestinal manifestations of systemic 
amyloidosis and discusses available methods for the diagnosis and 
treatment of systemic amyloidosis and its gastrointestinal consequences.
Abstract: http://links.ealert.nature.com/ctt?kn=86&m=34089817&r=MTc2OTYyOTQ2MwS2&b=2&j=NTg3MjEwNTES1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=47&m=34089817&r=MTc2OTYyOTQ2MwS2&b=2&j=NTg3MjEwNTES1&mt=1&rt=0
----------------------
CASE STUDY
----------------------
A case of complete resolution of gastric varices
Vanessa Tieu, George Behrens, Hector Ferral, Stanley M. Cohen and 
Joseph Ahn
p618 | doi:10.1038/nrgastro.2009.144
This article considers the case of a 49-year-old woman with a history 
of hepatitis C and peptic ulcer disease who presented with massive 
hematemesis. She was diagnosed with gastric variceal hemorrhage and 
splenic vein thrombosis. The patient underwent splenic artery 
embolization and balloon-occluded retrograde transvenous obliteration 
of gastric varices. By 30 months post-treatment no evidence of gastric 
varices or splenic vein thrombosis remained.
Abstract: http://links.ealert.nature.com/ctt?kn=85&m=34089817&r=MTc2OTYyOTQ2MwS2&b=2&j=NTg3MjEwNTES1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=83&m=34089817&r=MTc2OTYyOTQ2MwS2&b=2&j=NTg3MjEwNTES1&mt=1&rt=0
=========================== ADVERTISEMENT ===========================
Nature Reviews Gastroenterology and Hepatology reflects the attributes 
of the Nature Reviews series, now with an improved website and additional 
content. Nature Reviews Gastroenterology and Hepatology brings all its 
high-qualities features to the clinical sciences.
Visit Nature Reviews Gastroenterology and Hepatology online to experience 
the clinical sciences through Nature Reviews.
http://links.ealert.nature.com/ctt?kn=64&m=34089817&r=MTc2OTYyOTQ2MwS2&b=2&j=NTg3MjEwNTES1&mt=1&rt=0
=====================================================================
You have been sent this Table of Contents Alert because you have opted 
in to receive it. You can change or discontinue your e-mail alerts at 
any time, by modifying your preferences on your nature.com account at:
http://links.ealert.nature.com/ctt?kn=69&m=34089817&r=MTc2OTYyOTQ2MwS2&b=2&j=NTg3MjEwNTES1&mt=1&rt=0
(You will need to log in to be recognised as a nature.com registrant).
For further technical assistance, please contact our registration department:
registration@nature.com
For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com
For other enquiries, please contact our customer feedback department:
feedback@nature.com
Nature Publishing Group | 75 Varick Street, 9th Floor | New York |
NY 10013-1917 | USA
Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne - 
San Diego - San Francisco - Washington - New York - Boston
(c) Copyright 2009 Nature Publishing Group
=====================================================================
 
 
 
 
 

 






 
